Simultaneously slow low dose oral immunotherapy

Simultaneously slow low dose oral immunotherapy - double S-LOIT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041561

Enrollment

Registered

2020-08-26

Start date

2020-08-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children who have multiple severe food allergies among hen&#39

Interventions

Simultaneously slow low dose oral immunotherapy (ingesting Mikotama-cookie everyday with increaseing the dose at home whenever they could for every 30 consecutive intakes without obvious allergic sym

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with multiple severe food allergies to hen's egg, cow's milk, or wheat whose symptom-provoked total dose in the OFC 3.7g (mL) or lower.

Exclusion criteria

Exclusion criteria: uncontrolled bronchial asthma or atopic dermatitis

Design outcomes

Primary

Measure	Time frame
The result of oral food challenges after one-year of double S-OIT	—

Secondary

Measure	Time frame
feasibility of double S-LOIT safety of double S-LOIT	—

Countries

Japan

Contacts

Public ContactShiro Sugiura

Aichi Children's Health and Medical Center Department of Allergy

bee_jayz@hotmail.com0562-43-0500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026